ArticleCellular oncology (Dordrecht, Netherlands)2022

DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2.

Jiaqi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.